14159 capital gp llc - see footnote investment history in Viropharma inc

Filed on 2006-03-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-06-008352.txt Sec File: edgar/data/1317493/0001144204-06-008352-index.htm

2006-02-28 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc sold 7059 shares at $20.4109 remaining shares owned 25983

Common Stock Viropharma Inc Vphm Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each ofwhom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securitiesowned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filingsolely for informational purposes as if they were a member of a group with such shareholders. (continued in footnote 2.)
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposesof section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are thebeneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securitiesreported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limitedpartnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are thecontrolling members of 14159 capital (gp), llc.


Filed on 2006-03-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-06-008352.txt Sec File: edgar/data/1317493/0001144204-06-008352-index.htm

2006-02-28 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc sold 14346 shares at $19.8953 remaining shares owned 33042

Common Stock Viropharma Inc Vphm Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each ofwhom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securitiesowned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filingsolely for informational purposes as if they were a member of a group with such shareholders. (continued in footnote 2.)
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposesof section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are thebeneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securitiesreported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limitedpartnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are thecontrolling members of 14159 capital (gp), llc.


Filed on 2006-03-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-06-008352.txt Sec File: edgar/data/1317493/0001144204-06-008352-index.htm

2006-02-28 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc sold 40 shares at $21.8063 remaining shares owned 47388

Common Stock Viropharma Inc Vphm Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each ofwhom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securitiesowned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filingsolely for informational purposes as if they were a member of a group with such shareholders. (continued in footnote 2.)
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposesof section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are thebeneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securitiesreported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limitedpartnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are thecontrolling members of 14159 capital (gp), llc.


Filed on 2006-03-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-06-008352.txt Sec File: edgar/data/1317493/0001144204-06-008352-index.htm

2006-02-27 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc sold 2191 shares at $21.5799 remaining shares owned 47428

Common Stock Viropharma Inc Vphm Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each ofwhom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securitiesowned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filingsolely for informational purposes as if they were a member of a group with such shareholders. (continued in footnote 2.)
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposesof section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are thebeneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securitiesreported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limitedpartnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are thecontrolling members of 14159 capital (gp), llc.


Filed on 2006-03-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-06-008352.txt Sec File: edgar/data/1317493/0001144204-06-008352-index.htm

2006-02-27 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc sold 9779 shares at $21.7242 remaining shares owned 49619

Common Stock Viropharma Inc Vphm Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each ofwhom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securitiesowned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filingsolely for informational purposes as if they were a member of a group with such shareholders. (continued in footnote 2.)
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposesof section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are thebeneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securitiesreported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limitedpartnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are thecontrolling members of 14159 capital (gp), llc.


Filed on 2006-03-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-06-008352.txt Sec File: edgar/data/1317493/0001144204-06-008352-index.htm

2006-02-27 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc sold 9663 shares at $21.7430 remaining shares owned 59398

Common Stock Viropharma Inc Vphm Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each ofwhom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securitiesowned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filingsolely for informational purposes as if they were a member of a group with such shareholders. (continued in footnote 2.)
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposesof section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are thebeneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securitiesreported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limitedpartnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are thecontrolling members of 14159 capital (gp), llc.


Filed on 2005-05-12 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-05-015012.txt Sec File: edgar/data/1317493/0001144204-05-015012-index.htm

2005-05-10 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 10000 shares remaining shares owned 161000

60 Convertible Senior Secured Notes Due 2009 Viropharma Inc Vphm exercise price 2.50 has valueitem expiration due date 2009-10-18 underlying security shares 4000 underlying security title Common Stock

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each ofwhom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securitiesowned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filingsolely for informational purposes as if they were a member of a group with such shareholders. (continued in footnote 2.)
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposesof section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are thebeneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securitiesreported herein except to the extent of their pecuniary interest, if any, therein.
f5 130.50% of the principal amount.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limitedpartnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are thecontrolling members of 14159 capital (gp), llc.
f4 immediately.


Filed on 2005-05-12 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-05-015012.txt Sec File: edgar/data/1317493/0001144204-05-015012-index.htm

2005-05-10 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 24 shares at $2.6517 remaining shares owned 421

Common Stock Viropharma Inc Vphm Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each ofwhom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securitiesowned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filingsolely for informational purposes as if they were a member of a group with such shareholders. (continued in footnote 2.)
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposesof section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are thebeneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securitiesreported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limitedpartnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are thecontrolling members of 14159 capital (gp), llc.


Filed on 2005-05-12 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-05-015012.txt Sec File: edgar/data/1317493/0001144204-05-015012-index.htm

2005-04-28 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 204 shares at $1.7898 remaining shares owned 397

Common Stock Viropharma Inc Vphm Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each ofwhom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securitiesowned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filingsolely for informational purposes as if they were a member of a group with such shareholders. (continued in footnote 2.)
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposesof section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are thebeneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securitiesreported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limitedpartnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are thecontrolling members of 14159 capital (gp), llc.


Filed on 2005-05-04 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-05-013994.txt Sec File: edgar/data/1317493/0001144204-05-013994-index.htm

2005-05-02 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 32000 shares remaining shares owned 123000

60 Convertible Subordinated Notes Due 2007 Viropharma Inc Vphm exercise price 109.15 has valueitem expiration due date 2007-03-01 underlying security shares 293 underlying security title Common Stock

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each ofwhom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securitiesowned by it. because of certain relationships with other security holders of the issuer, the reporting persons have filed onschedule 13d as if they were a member of a group with such shareholders. however, the reporting persons disclaim that theyand any other person or persons in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange actof 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by such otherpersons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of theirpecuniary interest, if any, therein.
f4 89.250% of the principal amount.
f3 represents shares of notes owned directly by 14159, l.p., a limited partnership of which the sole general partner is 14159capital, l.p., a limited partnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julianc. baker are the controlling members of 14159 capital (gp), llc.
f2 immediately.


Filed on 2005-04-22 by 14159 Capital (Gp, Llc SEC CIK 1317493 Form 4

Accession 0001181431-05-023207.txt Sec File: edgar/data/1317493/0001181431-05-023207-index.htm

2005-04-21 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 30000 shares at $0 remaining shares owned 91000

60 Convertible Subordinated Notes Due 2007 Viropharma Inc Vphm exercise price 109.15 has valueitem expiration due date 2007-03-01 underlying security shares 274 underlying security title Common Stock

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons have filed on schedule 13d as if they were a member of a group with such shareholders. however, the reporting persons disclaim that they and any other person or persons, including those persons with whom the reporting persons have filed a schedule 13d, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f5 89.05% of the principal amount.
f4 represents shares of notes owned directly by 14159, l.p., a limited partnership of which the sole general partner is 14159 capital, l.p., a limited partnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are the controlling members of 14159 capital (gp), llc.
f2 immediately.


Filed on 2005-04-22 by 14159 Capital (Gp, Llc SEC CIK 1317493 Form 4

Accession 0001181431-05-023207.txt Sec File: edgar/data/1317493/0001181431-05-023207-index.htm

2005-04-21 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 20000 shares at $0 remaining shares owned 61000

60 Convertible Subordinated Notes Due 2007 Viropharma Inc Vphm exercise price 109.15 has valueitem expiration due date 2007-03-01 underlying security shares 183 underlying security title Common Stock

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons have filed on schedule 13d as if they were a member of a group with such shareholders. however, the reporting persons disclaim that they and any other person or persons, including those persons with whom the reporting persons have filed a schedule 13d, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 88.875% of the principal amount.
f4 represents shares of notes owned directly by 14159, l.p., a limited partnership of which the sole general partner is 14159 capital, l.p., a limited partnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are the controlling members of 14159 capital (gp), llc.
f2 immediately.


Filed on 2005-04-18 by 14159 Capital (Gp, Llc SEC CIK 1317493 Form 4

Accession 0001181431-05-022456.txt Sec File: edgar/data/1317493/0001181431-05-022456-index.htm

2005-04-14 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 5000 shares at $0 remaining shares owned 151000

60 Convertible Senior Secured Notes Due 2009 Viropharma Inc Vphm exercise price 2.5 has valueitem expiration due date 2009-10-18 underlying security shares 2000 underlying security title Common Stock

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons have filed on schedule 13d as if they were a member of a group with such shareholders. however, the reporting persons disclaim that they and any other person or persons, including those persons with whom the reporting persons have filed a schedule 13d, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 112.5% of the principal amount.
f4 represents shares of notes owned directly by 14159, l.p., a limited partnership of which the sole general partner is 14159 capital, l.p., a limited partnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are the controlling members of 14159 capital (gp), llc.
f2 immediately.


Filed on 2005-04-14 by 14159 Capital (Gp, Llc SEC CIK 1317493 Form 4

Accession 0001181431-05-022151.txt Sec File: edgar/data/1317493/0001181431-05-022151-index.htm

2005-04-12 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 41000 shares remaining shares owned 41000

60 Convertible Subordinated Notes Due 2007 Viropharma Inc Vphm exercise price 109.15 has valueitem expiration due date 2007-03-01 underlying security shares 375 underlying security title Common Stock

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons have filed on schedule 13d as if they were a member of a group with such shareholders. however, the reporting persons disclaim that they and any other person or persons, including those persons with whom the reporting persons have filed a schedule 13d, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 90.125% of the principal amount
f4 represents shares of notes owned directly by 14159, l.p., a limited partnership of which the sole general partner is 14159 capital, l.p., a limited partnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are the controlling members of 14159 capital (gp), llc.
f2 immediately.


Filed on 2005-03-02 by 14159 Capital (Gp, Llc SEC CIK 1317493 Form 4

Accession 0001181431-05-013837.txt Sec File: edgar/data/1317493/0001181431-05-013837-index.htm

2005-03-02 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 21000 shares remaining shares owned 146000

60 Convertible Senior Secured Notes Due 2009 Viropharma Inc Vphm exercise price 2.50 has valueitem expiration due date 2009-10-18 underlying security shares 8400 underlying security title Common Stock

f6 121% of the principal amount.
f4 represents notes owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are the controlling members of 14159 capital (gp), llc.
f2 immediately.


Filed on 2005-03-02 by 14159 Capital (Gp, Llc SEC CIK 1317493 Form 4

Accession 0001181431-05-013837.txt Sec File: edgar/data/1317493/0001181431-05-013837-index.htm

2005-03-01 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 10000 shares remaining shares owned 125000

60 Convertible Senior Secured Notes Due 2009 Viropharma Inc Vphm exercise price 2.50 has valueitem expiration due date 2009-10-18 underlying security shares 4000 underlying security title Common Stock

f5 115% of the principal amount.
f4 represents notes owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are the controlling members of 14159 capital (gp), llc.
f2 immediately.


Filed on 2005-03-02 by 14159 Capital (Gp, Llc SEC CIK 1317493 Form 4

Accession 0001181431-05-013837.txt Sec File: edgar/data/1317493/0001181431-05-013837-index.htm

2005-02-28 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 24000 shares remaining shares owned 115000

60 Convertible Senior Secured Notes Due 2009 Viropharma Inc Vphm exercise price 2.50 has valueitem expiration due date 2009-10-18 underlying security shares 9600 underlying security title Common Stock

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group with such security holders. however, the reporting persons disclaim that they and any other person or persons in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 110% of the principal amount.
f4 represents notes owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are the controlling members of 14159 capital (gp), llc.
f2 immediately.


Filed on 2005-02-14 by 14159 Capital (Gp, Llc SEC CIK 1317493 Form 4

Accession 0001181431-05-009864.txt Sec File: edgar/data/1317493/0001181431-05-009864-index.htm

2005-01-31 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 10000 shares remaining shares owned 91000

60 Convertible Senior Secured Notes Due 2009 Viropharma Inc Vphm exercise price 2.5 has valueitem expiration due date 2009-10-18 underlying security shares 4000 underlying security title Common Stock

f6 142.25% of the principal amount.
f2 represents shares and/or notes owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are the controlling members of 14159 capital (gp), llc.
f3 immediately.


Filed on 2005-02-14 by 14159 Capital (Gp, Llc SEC CIK 1317493 Form 4

Accession 0001181431-05-009864.txt Sec File: edgar/data/1317493/0001181431-05-009864-index.htm

2005-01-31 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 29000 shares remaining shares owned 81000

60 Convertible Senior Secured Notes Due 2009 Viropharma Inc Vphm exercise price 2.5 has valueitem expiration due date 2009-10-18 underlying security shares 11600 underlying security title Common Stock

f5 142% of the principal amount.
f2 represents shares and/or notes owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are the controlling members of 14159 capital (gp), llc.
f3 immediately.


Filed on 2005-02-14 by 14159 Capital (Gp, Llc SEC CIK 1317493 Form 4

Accession 0001181431-05-009864.txt Sec File: edgar/data/1317493/0001181431-05-009864-index.htm

2005-01-28 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 14000 shares remaining shares owned 52000

60 Convertible Senior Secured Notes Due 2009 Viropharma Inc Vphm exercise price 2.5 has valueitem expiration due date 2009-10-18 underlying security shares 5600 underlying security title Common Stock

f4 140% of the principal amount.
f2 represents shares and/or notes owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are the controlling members of 14159 capital (gp), llc.
f3 immediately.


Filed on 2005-02-14 by 14159 Capital (Gp, Llc SEC CIK 1317493 Form 4

Accession 0001181431-05-009864.txt Sec File: edgar/data/1317493/0001181431-05-009864-index.htm

2005-01-31 14159 Capital Gp Llc (CIK 1317493) through See Footnote

Invested in Viropharma Inc bought 193 shares at $3.0194 remaining shares owned 193

Common Stock Viropharma Inc Vphm Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c.baker and felix j. baker, each of whom has the same businessaddress as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with othersecurity holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group with such securityholders. however, the reporting persons disclaim that they and any other person or persons in fact constitute a "group" for purposes of section 13(d)(3) ofthe securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by such otherpersons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f2 represents shares and/or notes owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership of which the sole general partner is 14159 capital (gp), llc. felix j. baker and julian c. baker are the controlling members of 14159 capital (gp), llc.